Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Stock

24.64P/E
€14.43BMarket capitalisation
SEK18.99Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drugs, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).

Swedish Orphan Biovitrum AB is registered in the following country: Sweden (Exchange: SESSE).

Key metrics

Key metrics and master data for the Swedish Orphan Biovitrum AB stock.

Market capitalisation
€14.43B
P/E
24.64
P/B
3.58
P/S
5.12
P/CF
20.71
Issued shares 358M Units

Return

Here you can see the performance of the Swedish Orphan Biovitrum AB stock.

PeriodPerfor­mance
1 Week-4.61 %
1 Month+7.62 %
3 Months-0.19 %
6 Months+5.29 %
1 Year+38.94 %
YTD+35.96 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Swedish Orphan Biovitrum AB share.

DateRatio
07.12.20091:0.5

Which ETF contains the Swedish Orphan Biovitrum AB stock?

The Swedish Orphan Biovitrum AB stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Swedish Orphan Biovitrum AB has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Swedish Orphan Biovitrum AB stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.